S01-245C AntiPbx2 monoclonal antibody Researchers in the laboratory of Dr. Michael Cleary at Stanford University have developed anti-Pbx2 monoclonal antibodies to study transcriptional regulation, embryonic development, and tissue homeostasis. Michael Cleary Mrinmoy Sanyal